Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Cetuximab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 54 Head and Neck Neoplasms 51 Squamous Cell Carcinoma of Head and Neck 50 Carcinoma, Non-Small-Cell Lung 29 Rectal Neoplasms 21 Colonic Neoplasms 21 Carcinoma, Squamous Cell 16 Neoplasms 15 Neoplasm Metastasis 14 Lung Neoplasms 12 Pancreatic Neoplasms 11 Esophageal Neoplasms 11 Stomach Neoplasms 9 Recurrence 8 Tongue Neoplasms 7 Neoplasms, Squamous Cell 6 Mouth Neoplasms 6 Laryngeal Neoplasms 6 Carcinoma 6 Breast Neoplasms 6 Adenocarcinoma Of Esophagus 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Esophageal Squamous Cell Carcinoma 5 Adenocarcinoma of Lung 5 Oropharyngeal Neoplasms 4 Salivary Gland Neoplasms 3 Precancerous Conditions 3 Laryngeal Diseases 3 Hypopharyngeal Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡